I wrote about a “tranched fundraising round” on LinkedIn in early October 2026, describing why I favor SAFE‑native tranches over traditional priced rounds.
It is a SAFE‑native thing.
In a traditional priced round a founder might set out to raise $1 m.
Investors who commit late, once they know everyone else wants in, still get the exact same terms as the people who committed early and took on a lot more uncertainty.
A founder might say they want to raise $1m total, but carve out a smaller piece, say $300k, at more favorable investor terms.
If it fills really quickly, the valuation was probably set too low.
If it fills slowly even at an already‑low valuation, there's probably a bigger problem with the raise.
The first tranche is way more valuable than the second.